Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening

Tools

Preview	PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader 1MB
	Other (Supporting Information) 2MB

Item Type:	Letter
Title:	Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening
Creators Name:	El-Battrawy, I., Lan, H., Cyganek, L., Maywald, L., Zhong, R., Zhang, F., Xu, Q., Lee, J., Duperrex, E., Hierlemann, A., Saguner, A.M., Duru, F., Kovacs, B., Huang, M., Liao, Z., Albers, S., Müller, J., Dinkel, H., Rose, L., Hohn, A., Yang, Z., Qiao, L., Li, Y., Lang, S., Kleinsorge, M., Mügge, A., Aweimer, A., Fan, X., Diecke, S., Akin, I., Li, G. and Zhou, X.
Keywords:	Brugada Syndrome, Cardiac Death, Channelopathy, Short QT Syndrome
Source:	Clinical and Translational Medicine
ISSN:	2001-1326
Publisher:	Wiley
Volume:	11
Number:	12
Page Range:	e646
Date:	26 December 2021
Official Publication:	https://doi.org/10.1002/ctm2.646
PubMed:	View item in PubMed

Repository Staff Only: item control page

Download Statistics

Downloads

Downloads per month over past year